Sax Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Sax Wealth Advisors's REGN Position: Q2 2026 in Review
Sax Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 4.6% in Q2 2026, buying an estimated $9.53K and bringing the position to 316 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #490.
Sax Wealth Advisors first reported a position in REGN in Q3 2024 and has held it in 4 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Sax Wealth Advisors held 316 shares of Regeneron Pharmaceuticals worth $244K as of Q2 2026.
- Sax Wealth Advisors bought 14 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $9.53K.
- Regeneron Pharmaceuticals made up 0.01% of Sax Wealth Advisors's portfolio in Q2 2026, its #490 holding.
- Sax Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.